🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We're unaffected at Terraform Industries by grant freezes because despite spending years asking DoE to help out our process of increasing the supply of cheap carbon free hydrocarbons, we were awarded 0/20 grants. The officials were friendly and helpful but the emergent behavior of

Why test #celltherapies one-by-one when you can use multiplexed #SynBio, #proteinengineering & #ML to design, measure & track them at scale? The Goodman Lab Penn Medicine opens July 2025. We’re hiring Specialists & Postdocs! Apply @ bit.ly/42BnJNJ RTs appreciated!🙏

Check out Alli's talk on Monday 9AM at PEGS Boston. She'll be sharing a lot of new data from us

Great write-up by Bob Service at Science Magazine on this work. Quotes from Wei Wang, David Baker, and Andrew Bradbury check it out: science.org/content/articl…

Nice piece from Fay Lin, PhD Genetic Engineering & Biotechnology News on our recent advance in de novo antibody design for GPCRs

ICYMI we Dyno Therapeutics, Inc. unveiled 3 new capsids (delivering payloads to the Eye, CNS, and Neuromuscular) presented as oral spotlights in #ASGCT2025 this week! We also announced the first edition of the #GATC conference and our new frontiers program (if you are a startup in this space,

Today, we’re announcing the first major discovery made by our AI Scientist with the lab in the loop: a promising new treatment for dry AMD, a major cause of blindness. Our agents generated the hypotheses, designed the experiments, analyzed the data, iterated, even made figures

Scratch That? De Novo Antibody Design Enters the AI Drug Discovery Toolbox Debates over terminology clouded the mission of bringing better therapeutics to the clinic faster Nabla Bio HHMI Baker Lab Absci Generate:Biomedicines Caltech hubs.ly/Q03nqpw_0

AI hype or reality - can we design antibodies from scratch? In my latest article for Genetic Engineering & Biotechnology News, I unpack how arguments over terminology have clouded the industry’s shared mission of bringing better therapeutics to the clinic faster. tinyurl.com/4uamc8c5